NCT04457999Unknown不适用
Clinical Outcome of Lipiflow Treatment Prior to Cataract Surgery in Dry Eye Patients
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- improvement of dry eye symptom
研究概览
简要总结
To investigate the clinical outcome of Lipiflow treatment prior to cataract surgery in patients with meibomian gland dysfunction and dry eye disease
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients older than 21, who will get catarct surgeyr
- •Patients whose visual acuity anticipated better than 20/25 after surgery
- •Patients with informed consent
- •Patients with meibomian gland dysfunction
排除标准
- •ocular injury, active injection
- •uncontrolled systemic disease
- •Contact lens wear within 1 month
- •Allergic to fluorescein sodium or topical anesthetics
- •ocular surgery or trauma within 6 months
- •disorder of lid anatomy
- •other reason for decreased vision other than cataract
- •anticipated visual acuity less than 20/25
- •Patients less than 20 years.
结局指标
主要结局
improvement of dry eye symptom
时间窗: 1 month
ocular dryness
次要结局
未报告次要终点
研究者
tae-young chung
M.D. Ph.D
Samsung Medical Center
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Evaluation of Tear Film Lipid Layer Thickness Change After Cataract SurgeryCataract PatientsNCT02567565Yonsei University60
已完成
3 期
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry EyeDry Eye DiseaseNCT01743729Shire720
已完成
3 期
Safety Study of Lifitegrast to Treat Dry EyeDry Eye DiseaseNCT01636206Shire332
已完成
不适用
Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL) With an Improved Injector SystemAphakiaNCT02418871PowerVision53
已完成
不适用
Evaluation of the LipiFlow System With a New ActivatorMeibomian Gland DysfunctionNCT04500821Johnson & Johnson Surgical Vision, Inc.44